Cite
HARVARD Citation
Hamilton, P. et al. (2018). Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model. Nephrology dialysis transplantation. 33 (12), pp. 2145-2155. [Online].